Effect of low-dose rituximab on elderly patients with high risk membranous nephropathy： 2 cases and literature review

Effect of low-dose rituximab on elderly patients with high risk membranous nephropathy： 2 cases and literature review

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Zhao Xiao-yan, Wang Yao-min, Li Zheng, Chen Jiang-hua, Han Fei
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Nephrology 2025-02-01
Series:	Linchuang shenzangbing zazhi
Subjects:	geriatrics glomerulonephritis，membranous low-dose rituximab
Online Access:	http://www.lcszb.com/article/doi/10.3969/j.issn.1671-2390.2025.02.012
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of low-dose rituximab on elderly patients with high risk membranous nephropathy： 2 cases and literature review
by: Zhao Xiao-yan, et al.
Published: (2025-02-01)

Effectiveness of using rituximab in membranous nephropathy: a clinical case
by: I.M. Zavalna, et al.
Published: (2024-09-01)

Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease
by: Vanja Ivković, et al.
Published: (2025-03-01)

Ultra-low-dose rituximab is effective for the treatment of patients with minimal change disease - A retrospective study
by: Chang Wang, et al.
Published: (2025-07-01)

Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome
by: Paolo Cravedi, et al.
Published: (2024-11-01)

The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study
by: Xingli Zhou, et al.
Published: (2024-12-01)

Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis
by: Gabriel Sauvage, et al.
Published: (2025-03-01)

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy
by: Marco Allinovi, et al.
Published: (2025-08-01)

Efficacy and safety of rituximab for membranous nephropathy in adults: a meta-analysis of RCT
by: Baike Mao, et al.
Published: (2025-04-01)

Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab
by: Maria J. Vargas-Brochero, et al.
Published: (2025-08-01)

Therapeutic efficacy of low-dose rituximab for steroid-dependent minimal-change nephrotic syndrome in adults
by: Li Xiao-wei, et al.
Published: (2021-01-01)

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
by: Maxime Teisseyre, et al.
Published: (2025-03-01)

Clear cell renal cell carcinoma complicated with PLA2R-associated membranous nephropathy：three cases report and literature review
by: Sun Miao-xin, et al.
Published: (2025-02-01)

Long-term efficacy and safety of low-dose rituximab strategy in neuromyelitis optica spectrum disorder: a retrospective cohort study on treatment compliance and clinical outcomes
by: Yao Wang, et al.
Published: (2025-05-01)

Efficacy and safety of a B-cell-driven rituximab regimen for the treatment of refractory idiopathic membranous nephropathy
by: Kaiqi Guo, et al.
Published: (2025-07-01)

Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas
by: Katherine E. Lake, et al.
Published: (2025-07-01)

Membranous nephropathy in a patient with Sjögren’s disease
by: Kubra Kaynar, et al.
Published: (2025-05-01)

Clinical analysis of low-dos erituximab in the treatment of refractory idiopathic membranous nephropathy
by: Yuan Zhong-fei, et al.
Published: (2021-01-01)

Recent progress in the pathogenesis of membranous nephropathy
by: He Zhi-hua, et al.
Published: (2022-05-01)

A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy
by: Yi Wang, et al.
Published: (2024-12-01)

Study on predictors for treatment efficacy of rituximab in patients with PLA2R-negative primary membranous nephropathy
by: XU Lili, HU Xiaofan, LI Hao, WANG Weiming
Published: (2025-06-01)

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence
by: Alexandre Destere, et al.
Published: (2024-01-01)

Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy
by: Coralien H. Vink, et al.
Published: (2024-12-01)

Differential patterns of renal immunofluorescence staining for IgG subclass in membranous lupus nephritis infected with HBV and HBV associated membranous nephropathy
by: LU Jian-hua, et al.
Published: (2015-01-01)

Myeloperoxidase-Associated Membranous Nephropathy in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
by: Kenta Tominaga, et al.
Published: (2024-07-01)

Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
by: Stephen P. McAdoo, et al.
Published: (2025-06-01)

Advances in Multitarget Therapeutic Approaches for Immune-Mediated Glomerular Diseases
by: Luminita Voroneanu, et al.
Published: (2025-02-01)

The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study
by: Xinyang Li, et al.
Published: (2025-07-01)

Clear cell renal cell carcinoma complicated with PLA2R-associated membranous nephropathy：three cases report and literature review
by: Sun Miao-xin, et al.
Published: (2025-02-01)

Two cases report of low dose rituximab therapy for refractory nephrotic syndrome and literature review
by: ZHOU Qiao-dan, et al.
Published: (2018-01-01)

Primary Membranous Nephropathy with Crescents
by: Megana Sunder, et al.
Published: (2023-10-01)

Glomerulonephritis associated with marginal zone B-cell lymphoma: clinical, pathological characteristics of renal injury and treatment (clinical cases)
by: B. T. Dzhumabaeva, et al.
Published: (2015-12-01)

Rituximab in the treatment of refractory nephrotic syndrome with massive pleural effusion: one case report
by: Zhang Shuo-fan, et al.
Published: (2021-01-01)

Dose dependent rearrangement of cellular membranes induced by ionizing radiation
by: S. V. Khyzhnyak, et al.
Published: (2014-06-01)

Efficacy and safety of low dose rituximab in pemphigus: an updated systematic review and meta-analysis
by: Si-Han Liu, et al.
Published: (2025-07-01)

The role of repeat kidney biopsy in patients with lupus nephritis (case report)
by: N. Yu. Nikishin, et al.
Published: (2024-04-01)

Coexistence of anti-glomerular basement membrane disease and IgA nephropathy: an illustrative case and comprehensive literature review
by: Zewei Chen, et al.
Published: (2024-12-01)

Recent advances in the diagnosis and treatment of membranoproliferative glomerulonephritis with monoclonal immunoglobulin deposition
by: Zhang Yuan-yuan, et al.
Published: (2022-03-01)

Membranous glomerulonephritis and tuberculous peritonitis: a rare association
by: Biswadip Ghosh, et al.
Published: (2011-07-01)

Obinutuzumab for treatment of membranous nephropathy in patients positive and negative for the phospholipase A2 receptor antibody: case reports
by: Jinmeng Wang, et al.
Published: (2025-04-01)